메뉴 건너뛰기




Volumn 34, Issue 28, 2016, Pages 3480-3481

Pseudoprogression and measurement variability

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB; PEMBROLIZUMAB;

EID: 84990053013     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.67.6759     Document Type: Letter
Times cited : (12)

References (10)
  • 1
    • 84968779639 scopus 로고    scopus 로고
    • Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab
    • Hodi FS, Hwu WJ, Kefford R, et al: Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with pembrolizumab. J Clin Oncol 34:1510-1517, 2016
    • (2016) J Clin Oncol , vol.34 , pp. 1510-1517
    • Hodi, F.S.1    Hwu, W.J.2    Kefford, R.3
  • 2
    • 0038352143 scopus 로고    scopus 로고
    • Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response
    • Erasmus JJ, Gladish GW, Broemeling L, et al: Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 21:2574-2582, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 2574-2582
    • Erasmus, J.J.1    Gladish, G.W.2    Broemeling, L.3
  • 3
    • 78649905395 scopus 로고    scopus 로고
    • CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool
    • Nishino M, Guo M, Jackman DM, et al: CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Acad Radiol 18:54-62, 2011
    • (2011) Acad Radiol , vol.18 , pp. 54-62
    • Nishino, M.1    Guo, M.2    Jackman, D.M.3
  • 4
    • 80051725760 scopus 로고    scopus 로고
    • Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes
    • Oxnard GR, Zhao B, Sima CS, et al: Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. J Clin Oncol 29:3114-3119, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 3114-3119
    • Oxnard, G.R.1    Zhao, B.2    Sima, C.S.3
  • 5
    • 67650085792 scopus 로고    scopus 로고
    • Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small-cell lung cancer
    • Zhao B, James LP, Moskowitz CS, et al: Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small-cell lung cancer. Radiology 252:263-272, 2009
    • (2009) Radiology , vol.252 , pp. 263-272
    • Zhao, B.1    James, L.P.2    Moskowitz, C.S.3
  • 6
    • 84881128653 scopus 로고    scopus 로고
    • Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements
    • Nishino M, Giobbie-Hurder A, Gargano M, et al: Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements. Clin Cancer Res 19:3936-3943, 2013
    • (2013) Clin Cancer Res , vol.19 , pp. 3936-3943
    • Nishino, M.1    Giobbie-Hurder, A.2    Gargano, M.3
  • 7
    • 84883396112 scopus 로고    scopus 로고
    • RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: Comparison with RECIST 1.0
    • Nishino M, Cardarella S, Jackman DM, et al: RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: Comparison with RECIST 1.0. AJR Am J Roentgenol 201:W64-W71, 2013
    • (2013) AJR Am J Roentgenol , vol.201 , pp. W64-W71
    • Nishino, M.1    Cardarella, S.2    Jackman, D.M.3
  • 8
    • 84977123783 scopus 로고    scopus 로고
    • Optimizing immune-related tumor response assessment: Does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
    • Nishino M, Gargano M, Suda M, et al: Optimizing immune-related tumor response assessment: Does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? J Immunother Cancer 2:17, 2014
    • (2014) J Immunother Cancer , vol.2 , pp. 17
    • Nishino, M.1    Gargano, M.2    Suda, M.3
  • 9
    • 84930181050 scopus 로고    scopus 로고
    • Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment
    • Nishino M, Tirumani SH, Ramaiya NH, et al: Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment. Eur J Radiol 84:1259-1268, 2015
    • (2015) Eur J Radiol , vol.84 , pp. 1259-1268
    • Nishino, M.1    Tirumani, S.H.2    Ramaiya, N.H.3
  • 10
    • 84968873006 scopus 로고    scopus 로고
    • Adaptation of the immune-related response criteria: irRECIST
    • Bohnsack O, Hoos A, Ludajic K. Adaptation of the immune-related response criteria: irRECIST. ESMO 2014. (Abstract 4958)
    • ESMO 2014
    • Bohnsack, O.1    Hoos, A.2    Ludajic, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.